Alger SmallCap Growth Institutional Z-2 holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Alger SmallCap Growth Institutional Fund Class Z-2 AISZX
- NAV / 1-Day Return 21.57 / −2.04 %
- Total Assets 78.8M
-
Adj. Expense Ratio
1.000%
- Expense Ratio 1.000%
- Distribution Fee Level Above Average
- Share Class Type Institutional
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 500,000
- Status Open
- TTM Yield 0.00
- Turnover 39%
USD | NAV as of Oct 08, 2026 | 1-Day Return as of Oct 08, 2026, 12:59 AM GMT+0
Morningstar’s Analysis AISZX
Will AISZX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 28.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Cash | 6.45 | 5M | Cash and Equivalents |
Forte Biosciences Inc Ordinary Shares | 4.40 | 4M | Healthcare |
Chime Financial Inc Ordinary Shares - Class A | 4.18 | 3M | Technology |
Guardant Health Inc | 3.18 | 3M | Healthcare |
Gates Industrial Corp Ltd | 2.94 | 2M | Industrials |
Victoria's Secret & Co | 2.70 | 2M | Consumer Cyclical |
RBC Bearings Inc | 2.57 | 2M | Industrials |
Tutor Perini Corp | 2.50 | 2M | Industrials |
Adaptive Biotechnologies Corp | 2.27 | 2M | Healthcare |
Absci Corp | 1.80 | 1M | Healthcare |